Abstract:Abstract Background: Epidemiological and experimental studies have indicated that an increase of plant proteins in diets, as well as a substitution of red meat proteins or processed meat proteins with plant proteins, was closely associated with the reduction of cardio-cerebrovascular disease (CVD)-related mortality. One of the most important ways of plant proteins to reduce the incidence rate of CVD is to lowering cholesterol concentration in serum and liver. Mounting evidences have attributed this effect of plant proteins to their regulation of gut microbiota. However, it remains to be elucidated whether gut microbiota play decisive roles in modulating host cholesterol by dietary protein from diverse sources of plant or meat. This study attempted to clarify the relevant mechanisms by comparing the difference in cholesterol metabolism modulation between pea and pork proteins intake of hypercholesterolemia hamster, as well as its relationships with gut microbiome and metabolic pathway. Results: We have verified that there are significant differences in the regulations of serum and liver cholesterol levels among different proteins intake from plants (rice, oat, soybean, pea) or meat (chicken, pork, beef), and the corresponded differences in gut microbiota were also observed. The decisive roles of gut microbiota in regulating host cholesterol were illustrated by the findings that the differences in serum cholesterol level between pea protein and pork protein disappeared in the hamsters treated with antibiotics. The experimental results of cross-over intervention of pea and pork protein showed that the serum cholesterol level was reversed with dietary exchange. Most interestingly, the corresponded changes in abundance of dominant bacteria suggested that the “beneficial” microbe Muribaculaceae were responsible for the inhibitory effect of pea protein on serum cholesterol level, while the opposite effect of pork protein was due to the “harmful” microbe Erysipelotrichaceae . Moreover, dietary pea protein supplement altered cecal metabolites including changes in arginine/histidine pathway, primary bile acid biosynthesis, short chain fatty acids or other lipid-like molecules, which involved in cholesterol metabolism. Conclusion: Dietary pea protein exerted cholesterol-lowering effects through modulating the growth of selected gut microbiota in hamsters. The substitution of pork protein with pea protein could reshape the gut microbiota, affect the contents of metabolites in caecum, and thus regulate cholesterol metabolism. These findings suggest specific bacteria and metabolites can be potential therapeutic targets of hypercholesterolemia by plant protein intervention.

The Soluble Fraction of Soy Protein Peptic Hydrolysate Reduces Cholesterol Micellar Solubility and Uptake

Disrupting Effect of Peptides Derived fromin Vitro Digestion of Tofu Protein on the Transportation of Micellar Cholesterol

Impact of soy proteins, hydrolysates and monoglycerides at the oil/water interface in emulsions on interfacial properties and emulsion stability

Combined effects of atorvastatin and soybean isoflavones on hypercholesterolemia and lipoprotein metabolism

Effects of ultrasound pretreatment on the enzymatic hydrolysis of soy protein isolates and on the emulsifying properties of hydrolysates

The Effect of Whey Protein Isolate Hydrolysate on Digestive Properties of Phytosterol

Characterization of the structure, antioxidant activity and hypoglycemic activity of soy (Glycine max L.) protein hydrolysates

Mild Preheating Improves Cholesterol-Lowering Benefits of Soy Protein Via Enhancing Hydrophobicity of Its Gastrointestinal Digests: an in Vitro Study

Maximizing Cholesterol-Lowering Benefits of Soy Protein Isolate by Glycation with Soy Soluble Polysaccharide

The Chemistry Behind the Antioxidant Actions of Soy Protein Isolate Hydrolysates in a Liposomal System: Their Performance in Aqueous Solutions and Liposomes.

Interaction of Soybean 7S Globulin Peptide with Cell Membrane Model Via Isothermal Titration Calorimetry, Quartz Crystal Microbalance with Dissipation, and Langmuir Monolayer Study.

Hexagonal plate ultrasound pretreatment on the correlation between soy protein isolate structure and cholesterol-lowering activity of peptides, and protein's enzymolysis kinetics, thermodynamics

Condensation of Soy Protein Peptides Contributes to Sequester Bile Acids and Mitigate LPS-Induced Inflammation

Fabrication of Soy Protein Nanoparticles Via Partial Enzymatic Hydrolysis and Their Role in Controlling Lipid Digestion of Oil-in-Water Emulsions

Pea Protein Reduce Serum Cholesterol Levels in Hypercholesterolemia Hamsters by Modulating Compositions of Gut Microbiota and Metabolites

Soy proteins as vehicles for enhanced bioaccessibility and cholesterol-lowering activity of phytosterols

Co-extraction of soy protein and polysaccharide with lipid-lowering activity: Characterization of functional property, nutritional property and colonic fermentation property through a metabolomics approach

Effect of soluble dietary fiber on soy protein isolate emulsion gel properties, stability and delivery of vitamin D 3

Effect of thermosonication pre-treatment on mung bean (Vigna radiata) and white kidney bean (Phaseolus vulgaris) proteins: Enzymatic hydrolysis, cholesterol lowering activity and structural characterization

Soybean-Derived Peptides Attenuate Hyperlipidemia by Regulating Trans-Intestinal Cholesterol Excretion and Bile Acid Synthesis

Interaction of soy protein isolate with hydroxytyrosol based on an alkaline method: Implications for structural and functional properties